List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 127 studies with search of: "Spasticity "
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Conditions: Spasticity;   Cerebral Palsy
Intervention: Drug: baclofen
2 Completed Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity
Condition: Muscle Spasticity
Intervention: Drug: Tizanidine (sublingual or oral)
3 Completed Vanderbilt University Spasticity Management Program Evaluation Plan
Condition: Spasticity
Interventions: Drug: Botulinum Toxin Type A;   Drug: Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB)
4 Active, not recruiting Evaluate the Maintenance of Effect After Long-Term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
5 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Condition: Muscle Spasticity
Interventions: Drug: tolperisone HCl (AV650);   Drug: Placebo
6 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Condition: Muscle Spasticity
Intervention: Drug: tolperisone HCl
7 Completed The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Intervention: Procedure: Penile Vibratory Stimulation
8 Completed A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
9 Recruiting Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
Intervention:
10 Completed Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
Conditions: Muscle Spasticity;   Cerebrovascular Accident
Interventions: Drug: Botulinum toxin type A (Dysport®);   Other: Placebo
11 Completed Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Conditions: Mental Retardation;   Spasticity
Intervention:
12 Recruiting Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
Condition: Focal Upper Limb Spasticity
Interventions: Drug: Botulinum toxin type A, BoNT-A;   Other: Rehabilitation Therapy
13 Completed Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
Conditions: Multiple Sclerosis;   Muscle Spasticity;   Spinal Cord Injury;   Stroke
Intervention: Drug: tizanidine hydrochloride capsule
14 Completed Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Intervention: Drug: Fampridine-SR
15 Recruiting Efficacy of Functional Electrical Stimulation (FES) in Persons Receiving Botulinum Neurotoxin for Upper Extremity Spasticity
Conditions: Upper Extremity Spasticity;   Stroke;   Acquired Brain Injury
Intervention: Device: Functional Electrical Stimulation (FES) through the Ness H200
16 Not yet recruiting Continuous Intrathecal Baclofen Infusion for Chronic Spasticity
Condition: Spasticity
Intervention: Device: Prometra Programmable Implantable Pump System
17 Completed Effects on Quality of Life Following Dysport Treatment in Post-Stroke Spasticity of the Arm
Conditions: Cerebrovascular Accident;   Muscle Spasticity
Intervention: Drug: Botulinum type A toxin (Dysport)
18 Recruiting Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A from laboratory Lanzhou;   Drug: Botulinum toxin type A from laboratory Allergan
19 Completed Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Smoked Cannabis
20 Recruiting Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services